findmyKOL
Clinical trialNCT01922050CompletedPhase 1/PHASE2Interventional

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

SponsorLEO PharmaEnrollment320Actinic Keratosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Gary Goldenberg, MD

    Mount Sinai School of Medicine, Dermatology Faculty

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Stratica Medical Inc.

    Edmonton, Alberta, Canada

  • Guildford Dermatology Specialists

    Surrey, British Columbia, Canada

  • Durondel C.P. Inc./dermatology Clinic

    Moncton, New Brunswick, Canada

  • Ultranova Skincare

    Barrie, Ontario, Canada

  • Co-Medica Research Network Inc.

    Courtice, Ontario, Canada

  • Dermatrials Research Incorporated

    Hamilton, Ontario, Canada

  • the Guenther Dermatology Research Centre

    London, Ontario, Canada

  • Lynderm Research Inc.

    Markham, Ontario, Canada

  • Skin Centre for Dermatology

    Peterborough, Ontario, Canada

  • K. Papp Clinical Research

    Waterloo, Ontario, Canada

  • Xlr8 Medical Research

    Windsor, Ontario, Canada

  • Centre de Recherche Dermatologique Du Quebec Metropolitain

    Québec, Quebec, Canada

United States
  • Omni Dermatology

    Phoenix, Arizona, United States

  • Torrance Clinical Research Institute Inc.

    Lomita, California, United States

  • Dermatology Cosmetic Laser Medical Associates of la Jolla, Inc.

    San Diego, California, United States

  • Leavitt Medical Associates of Florida

    Ormond Beach, Florida, United States

  • Clinical Research Center, Morsani Center for Advanced Healthcare

    Tampa, Florida, United States

  • Hudson Dermatology, Llc

    Evansville, Indiana, United States

  • Research Institute of Deaconess Clinic

    Evansville, Indiana, United States

  • Dermassociates, Pc

    Rockville, Maryland, United States

  • Great Lakes Research Group, Inc.

    Bay City, Michigan, United States

  • Henry Ford Medical Center, Dept. of Dermatology

    West Bloomfield, Michigan, United States

  • the Dermatology Group, P.C.

    Verona, New Jersey, United States

  • Mount Sinai School of Medicine

    New York, New York, United States

  • Clinical Trials of Texas, Inc.

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2013
Primary completion
30 Nov 2014
Completion
30 Nov 2014
Last update posted
6 Mar 2025
Registered enrollment
320
Registry id
NCT01922050

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.